OBM Transplantation is an international peer-reviewed Open Access journal, which covers all evidence-based scientific studies related to transplantation, including: transplantation procedures and the maintenance of transplanted tissues or organs; assimilation of grafted tissue and the reconstitution of removed organs or parts of organs; transplantation of heart, lung, kidney, liver, pancreatic islets and bone marrow, etc. Areas related to clinical and experimental transplantation are also of interest.
OBM Transplantation is committed to rapid review and publication, and we aim at serving the international transplant community with high accessibility as well as relevant and high quality content.
We welcome original clinical studies as well as basic science, reviews, short reports/rapid communications, case reports, opinions, technical notes, book reviews as well as letters to the editor.
Archiving: full-text archived in CLOCKSS.
Rapid publication: manuscripts are undertaken in 8 days from acceptance to publication (median values for papers published in this journal in 2021, 1-2 days of FREE language polishing time is also included in this period).
Submission Deadline: July 31, 2017 (Open) Submit Now
Nandini Nair, PhD, MD, FSVM, FACC, FACP
Professor of Medicine, Cardiology - Adv HF/MCS/Transplant Cardiology at Texas Tech University Health Sciences Center, Lubbock, TX, USA
Research Interests: antibody mediated rejection; cardiac allograft vasculopathy; role of VADS in diastolic dysfunction; molecular mechanisms underlying heart failure and developing diagnostics and therapeutics
About This Topic
OBM Transplantation publishes peer-reviewed research across the full spectrum of biomedical science, and clinical research and practice in organ transplantation. The journal welcomes experimental, translational and clinical approaches in a special issue directed at Allograft Vasculopathy guest edited by Nandini Nair MD, PhD, FACC, FACP, Texas Tech Health Sciences Center, Lubbock, TX, USA. The journal is seeking original research manuscripts, focused reviews, brief reports, and research letters that address any aspect of allograft vasculopathy, including but not limited to basic mechanisms, epidemiology, pathophysiology, diagnosis, management, and prognosis.
The deadline for submission of manuscripts for consideration for this focus issue is 31st July, 2017. All papers will undergo expedited review with prompt turnaround. All submissions should have a note in the cover letter that they are being submitted for the focus issue.
Please submit manuscripts online via our website. We look forward to receiving your submissions.
Received: 31 May 2017; Published: 28 September 2017; doi: 10.21926/obm.transplant.1703005
Cardiac allograft vasculopathy(CAV) is one of the leading causes of death following the first 5 years after orthotopic heart transplantation(OHT) along with late graft failure( likely secondary to undiagnosed CAV. Currently there is no single medical treatment available for this condition except modification of risk factors and immunosuppres [...]
To prevent robots and page crawlers from submitting fraudulent forms, complete verification to prove that you are a human.